Sec Form 4 Filing - KINGSLEY ALFRED D @ BIOTIME INC - 2017-07-01

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
KINGSLEY ALFRED D
2. Issuer Name and Ticker or Trading Symbol
BIOTIME INC [ BTX]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X __ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
See Remarks
(Last) (First) (Middle)
150 E. 57TH STREET
3. Date of Earliest Transaction (MM/DD/YY)
07/01/2017
(Street)
NEW YORK, NY10022
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Shares, no par value 5,931,555 ( 1 ) D
Common Shares, no par value 1,143,346 I By Greenbelt Corp.
Common Shares, no par value 375,351 I By Greenway Partners, LP
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Option to Purchase Common Shares $ 3.15 07/01/2017 A 50,000 ( 2 ) 06/30/2022 Common Shares 50,000 $ 0 50,000 D
Option to Purchase Common Shares $ 2.72 ( 3 ) 06/30/2021 Common Shares 50,000 50,000 D
Option to Purchase Common Shares $ 3.57 ( 4 ) 06/30/2020 Common Shares 50,000 50,000 D
Option to Purchase Common Shares $ 3.11 ( 5 ) 06/30/2019 Common Shares 50,000 50,000 D
Option to Purchase Common Shares $ 4.13 ( 6 ) 06/30/2018 Common Shares 50,000 50,000 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
KINGSLEY ALFRED D
150 E. 57TH STREET
NEW YORK, NY10022
X See Remarks
Signatures
/s/Alfred D. Kingsley 07/05/2017
Signature of Reporting Person Date
Explanation of Responses:
( 1 )Does not include shares that Mr. Kingsley may acquire through the exercise of certain options.
( 2 )Will become exercisable in four equal quarterly installments after the date of grant on July 1, 2017 based upon continued service on the board of directors.
( 3 )Became exercisable in four equal quarterly installments after the date of grant on July 1, 2016.
( 4 )Became exercisable in four equal quarterly installments after the date of grant on July 1, 2015.
( 5 )Became exercisable in four equal quarterly installments after the date of grant on July 1, 2014.
( 6 )Became exercisable in four equal quarterly installments after the date of grant on July 1, 2013.

Remarks:
Mr. Kingsley is Chairman of certain BioTime subsidiaries.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.